Dendritic polypeptide-based nanocarriers for the delivery of therapeutic agents
US9943606B2 · kind B2 · utility
1Cited by
15References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 12, 2015 |
| Grant date | Apr 17, 2018 |
| Priority date | — |
| Expiry date | Oct 12, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Dendritic polypeptides useful for the delivery of therapeutic agents into cells are disclosed, together with their methods of preparation. These dendritic polypeptides serve as carriers of drugs, siRNA, aptamers and plasmid DNA in the treatment of various diseases, including cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.